PrintNEWS
The life sciences in the news[Please login to post comments]
- Boon for Biodefense
Cellerant and Achaogen rack up millions in new contracts. Read More - Knowing What You Know
Comparative effectiveness research comes to the FDA – but in a good way – sort of. Read More - Another Specialty Buy for Pfizer
FoldRX acquisiton adds to neuroscience portfolio. Read More - A Crossword A Day Does Not Keep Mental Decline Away
Brain exercises may slow loss of cognitive abilities, but speed up dementia later. Read More - A Big Bet on Biofuels
Shell and Cosan joint venture moves closer to reality. Read More - Remarkable Result in Melanoma Drug Trial
Study drug shrinks tumors in 81 percent of melanoma patients. Read More - Roche Bets Big on Aileron
Partners see promise in peptides for tackling tough diseases. Read More - Actos and Avandia pose similar risks
New study contrasts with earlier findings on top diabetes drugs. Read More - Legislators Weigh Goals of Personalized Medicine Bill
Podcast: August 30, 2010 Read More - Retrovirus Linked to Chronic Fatigue Syndrome
Study could open new avenues of treating a debilitating disease. Read More
.jpg)
.gif)
.gif)
.png){kind=small}
- Sanofi Chief Extends Hand to Bypass Genzyme `Brick Wall'
Bloomberg - U.S. Court Rules Against Obama’s Stem Cell Policy
The New York Times - Takeda Says Lifestyle-Disease Drugs Will Drive Growth
Bloomberg - Study Says Brain Trauma Can Mimic Lou Gehrig’s Disease
The New York Times - Two New Paths to the Dream: Regeneration
The New York Times - Medical Device Makers Face Revamped U.S. Rules for Approvals
Bloomberg - Pfizer May Gain as U.S. Devises Speedy Alternative to Animal Safety Tests
Bloomberg - Judge lets Virginia healthcare challenge proceed
Reuters - F.D.A. Clears Way for Embryonic Stem Cell Trial Using Patients
The New York Times - Technologies Help Adult Children Monitor Aging Parents
The New York Times